Cisplatin-resistance involves the defective processing of MEKK1 in human ovarian adenocarcinoma 2008/C13 cells.

International journal of oncology

Volumn 16, Issue 2, 2000, Pages 321-325

  Gebauer, G ^a   Mirakhur, B ^a   Nguyen, Q ^a   Shore, S K ^a   Simpkins, H ^a   Dhanasekaran, N ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; MAP3K1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN SERINE THREONINE KINASE; STRESS ACTIVATED PROTEIN KINASE;

ADENOCARCINOMA; ARTICLE; CELL CULTURE; DRUG EFFECT; DRUG RESISTANCE; FEMALE; HUMAN; METABOLISM; OVARY TUMOR; PHYSIOLOGY;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; OVARIAN NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0034132566     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.16.2.321     Document Type: Article

References (0)